With the aid of these universities, Mobecomm performed clinical trials and studies to confirm the claimed sensitivity and specificity of its device.
According to Fazilah, these early stages involved significant leaps of faith, as some medical professionals had to sign off on reports on the presence or absence of cancer in the breast, which carried immense liabilities.
Mobecomm also conducted seminars for focus groups in the medical community to introduce the technology and obtain feedback.
Then came a series of collaborations with private clinics, imaging centres and non-governmental organisations (NGOs) to introduce the new technology and assist cancer patients and their families.
Mobecomm also offered over 50,000 breast screening services to the female workforce of corporations and government departments at their work premises.
Through those challenging years, the company overcame barrier after barrier, and has now succeeded in convincing many in the medical profession of the real benefits of its technology.
Driven by passion
The ups and downs sometimes took a toll on Fazilah, and she admits that there were times when she felt like giving up.
It was her business partner's support that helped her to pull through. She also held firmly to her mission to defeat cancer through early detection.
“The only reason we are still here and getting stronger after several falls is that we are driven not by revenue, but by our passion. We are determined to defeat breast cancer,” says Fazilah.
“Most of us have seen or know of someone suffering from breast cancer, and we know the pain and trauma inflicted upon not only the woman with breast cancer, but the entire family.
“This is what drives us to continue our efforts,” she adds.
This persistence has started to pay off. Mobecomm's proudest moment came when it was invited by KPJ International Group to offer breast-screening services during its medical tourism campaign in Dubai, Oman and Kuwait.
“Receiving an invitation by a group of that stature to participate in international events, shows how far we’ve come from being rejected by regular clinics whose doctors had refused to see us even after we had waited for them for hours,” says Fazilah.
Mobecomm is also proud to have trained MEIK device distributors, doctors and nurses from other countries, as this has helped establish Malaysia as a training and consulting centre for the Asian region.
In addition to gaining a Merit Award and the CIP 500 from the Cradle Fund, Mobecomm has also obtained GDPMM and ISO 9001 Certifications.
Saving lives around the world
Fazilah says the Coach and Grow Programme (CGP) played a critical role on the road to business success. The programme helped light her path through the minefield of rejections and difficulties.
Describing the CGP as highly significant, Fazilah says the programme helped Mobecomm to strategically position its product and successfully market its breast-screening services.
This gave it the impetus and confidence to forge alliances with strategic partners, and to expand its business.
It is Fazilah’s fervent hope that MEIK technology will be able to reduce breast cancer occurrence rates, improve survival rates, and reduce treatment costs in Malaysia through pre-emptive intervention and early detection.
This year, Mobecomm plans to extend its vision to the Association of South-East Asian Nations (Asean) region, and in the long-term, develop nanotechnology based on non-invasive and radiation-free pre- and early cancer detection.
Through it all, Fazilah never let go of her original vision of making a difference. She knows in her heart that the day will come when Mobecomm will save countless lives around the world.
Discover Mobecomm Technologies at www.mobecomm.com.
The above is an excerpt from the book Startups to Scaleups published in October 2015 by Cradle Fund and Proficeo Consultants, the programme manager for Cradle’s Coach and Grow Programme. DNA will be featuring every entrepreneurial story from the book in a special commercial arrangement.